Year: 2022

Delta 9 Reports Financials for Q3 2022

Written by Customer Service on November 15, 2022. Posted in Earnings Releases And Operating Results.

WINNIPEG, Manitoba, Nov. 14, 2022 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: DLTNF) (“Delta 9” or the “Company”), is pleased to announce financial and operating results for the three-month and nine-month period ending September 30, 2022. Financial Highlights for the three-month period ending September 30, 2022Net revenue of $15.7 million for the third quarter of 2022, an increase of 3%, from $15.2 million for the same quarter last year. Gross profit of $1.9 million for the third quarter of 2022, versus $4.8 million for the same quarter last year. Net income (loss) from operations of $(6.2) million for the third quarter of 2022 versus a net income (loss) from operations of $(55,031) for the same quarter last year. Adjusted EBITDA (loss) of $(1.7) million for the third quarter of 2022 versus an adjusted EBITDA of...

Nexus Industrial REIT Announces Q3 2022 Results and December Distribution

Written by Customer Service on November 15, 2022. Posted in Dividend Reports And Estimates.

TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) — Nexus Industrial REIT (the “REIT”) (TSX: NXR.UN) announced today its results for the quarter ended September 30, 2022. HighlightsOn November 1, 2022, the REIT acquired a 435,871 square foot portfolio of four industrial properties occupied by a single tenant for $38.2 million ($28.5 USD million). Three of the properties are located in Windsor, Ontario and one is located in Tilbury, Ontario. On October 4, 2022, the REIT sold a retail property located in Longueuil, Quebec for $11.9 million. On September 30, 2022, the REIT acquired an industrial property located in Cornwall, Ontario for $4.9 million. The property is occupied by one of the REIT’s existing tenants. On September 8, 2022, the REIT acquired a single-tenant 74,681 square foot industrial property located in the Montreal area for...

Rubicon Organics to Hold Annual General and Special Meeting

Written by Customer Service on November 15, 2022. Posted in Public Companies.

VANCOUVER, British Columbia, Nov. 14, 2022 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis, is pleased to announce that it will hold its Annual General and Special Meeting (the “Meeting”) of shareholders at 10:00 AM PT on December 13, 2022 in person at the Terminal City Club, 837 West Hastings Street, Vancouver, British Columbia, V6C 1B6, for the following purposes:to receive the audited financial statements of the Company for the financial year ended December 31, 2021, together with the report of the Company’s auditors thereon; to set the number of directors of the Company at five (5); to elect directors of the Company for the ensuing year; to appoint PricewaterhouseCoopers...

Montage Technology Selects PDF Solutions® Exensio® Fabless for Advanced Semiconductor Analytics

Written by Customer Service on November 15, 2022. Posted in Public Companies.

Exensio Platform Drives Adoption of Big Data Analytics with Powerful and Customizable Templates SANTA CLARA, Calif., Nov. 14, 2022 (GLOBE NEWSWIRE) — PDF Solutions, Inc. (Nasdaq: PDFS), a leading provider of unified data and cloud analytics for the semiconductor ecosystem, today announced that Montage Technology selected PDF Solutions’ Exensio Fabless as its semiconductor analytics platform. Exensio Fabless is designed with a powerful and flexible analytics environment, which PDF Solutions believes was a critical factor in the decision. Montage Technology is a leading IC design company dedicated to providing high-performance, low-power IC solutions for cloud computing and data center markets. After a comprehensive evaluation, Montage chose PDF Solutions’ Exensio Fabless as its yield data analysis platform. The template function...

Noranda Income Fund Announces Third Quarter 2022 Results

Written by Customer Service on November 15, 2022. Posted in Earnings Releases And Operating Results.

TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) — Noranda Income Fund (TSX:NIF.UN) (the “Fund”) today reported its financial results for the third quarter ended September 30, 2022. Except where otherwise indicated, all amounts in this press release are expressed in US dollars. Third Quarter 2022 Highlights (compared to same period in 2021)Loss before income taxes of $16.9 million, including an unrealized derivative financial instrument loss of $33.4 million and an impairment of non-financial assets of $30.0 million, compared to earnings before income taxes of $5.9 million, including an unrealized derivative financial instrument loss of $0.1 million Adjusted EBITDA1 of $40.4 million, compared to $7.8 million Zinc metal production of 53,003 tonnes, compared to 64,063 tonnes Zinc metal sales of 54,235 tonnes, compared to 63,676 tonnes“Our...

Reborn Coffee Reports Third Quarter 2022 Financial Results

Written by Customer Service on November 15, 2022. Posted in Earnings Releases And Operating Results.

BREA, Calif., Nov. 14, 2022 (GLOBE NEWSWIRE) — Reborn Coffee, Inc. (NASDAQ: REBN) (“Reborn”, or the “Company”), a California-based retailer of specialty coffee, has reported its financial and operational results for the third quarter ended September 30, 2022. Key Financial and Operational Highlights for the Third Quarter 2022Revenue increased 22% to $0.8 million in Q3’22 compared to $0.7 million in Q3’21. Revenue increased 52% in the nine months ended September 30, 2022 to $2.4 million, up from $1.6 million during same period in 2021. Announced plans to open five new Company-owned retail locations in Southern California, which, if and when opened, will bring total count to fourteen stores. On August 16, 2022, the Company completed an upsized initial public offering (the “IPO”), selling 1,440,000 shares at $5.00 per share. Net...

Clearmind Medicine Announces Pricing of US$7.5 Million Public Offering and Uplisting to the Nasdaq Capital Market

Written by Customer Service on November 15, 2022. Posted in Public Companies.

VANCOUVER, Nov. 14, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq and CSE: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, today announced the pricing of its underwritten public offering of 1,153,847 common shares at a price to the public of US$6.50 per share (CAD$8.65), for aggregate gross proceeds of US$7.5 million, prior to deducting underwriting discounts and offering expenses. The pricing occurs following a 1-for-30 reverse stock split, which was effective at 5:30 p.m. on September 30, 2022. In addition, the Company has granted Aegis Capital Corp. (“Aegis”) a 45-day option to purchase up to 173,077 additional common shares, equal to 15% of the number of shares sold in the...

Fast Radius Establishes Timeline for Chapter 11 Sale Process

Written by Customer Service on November 15, 2022. Posted in Public Companies.

Fast Radius continues operating and serving customers in the normal course CHICAGO, Nov. 14, 2022 (GLOBE NEWSWIRE) — Fast Radius, Inc. (Nasdaq: FSRD) (“Fast Radius” or the “Company”) received approval today from the United States Bankruptcy Court for the District of Delaware for its proposed sale and marketing procedures, including a bid deadline of December 5, 2022. The Company is in active discussions with one or more potential partners and continues to explore and evaluate strategic alternatives, including from newly interested parties. “We are pleased to have received approval of the bid procedures. This allows us to finish marketing our business and our first-of-its-kind Cloud Manufacturing Platform on an expedited timeline while continuing to serve our customers without interruption,” said Lou Rassey, Co-Founder and...

Condor Announces 2022 Third Quarter Results

Written by Customer Service on November 15, 2022. Posted in Earnings Releases And Operating Results.

CALGARY, Alberta, Nov. 14, 2022 (GLOBE NEWSWIRE) — Condor Energies Inc. (“Condor” or the “Company”) (TSX: CDR), a Canadian based energy transition company with activities in Turkiye and Kazakhstan, is pleased to announce the release of its unaudited interim condensed consolidated financial statements for the three and nine months ended September 30, 2022 together with the related management’s discussion and analysis. These documents will be made available under Condor’s profile on SEDAR at www.sedar.com and on the Condor website at www.condorenergies.ca. Readers are invited to review the latest corporate presentation available on the Condor website. All financial amounts in this news release are presented in Canadian dollars, unless otherwise stated. HighlightsThe Company has entered into a binding sale and purchase agreement...

Junshi Biosciences Announces Submission of a Marketing Authorization Application to the European Medicines Agency for Toripalimab

Written by Customer Service on November 15, 2022. Posted in Public Companies.

–The MAA was submitted in the EU for toripalimab seeking indications for the 1st line treatment of NPC and the 1st line treatment of ESCC — The global commercialization plan for toripalimab has expanded from China to the US and now, the EU SHANGHAI, China, Nov. 15, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the company has submitted a marketing authorization application (“MAA”) to the European Medicines Agency (“EMA”) for toripalimab. The indications requested in the MAA are:Toripalimab combined with cisplatin and gemcitabine for the first-line treatment of patients with locally recurrent or...

Year: 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals